Michael Yaffe Laboratory, , Charité — University Medicine Berlin, 2016 .

Michael Yaffe Laboratory, edu Articles 1–20 Michael YAFFE, David H. Koch Professor | Cited by 41,587 | of Massachusetts Institute of Technology, MA (MIT) | Read 482 publications | Contact Michael YAFFE Feb 1, 2018 · Michael Yaffe heads the MIT Center for Precision Cancer Medicine February 1, 2018 | MIT News Current lab members Alexander Bungert Visiting Scientist bungerta@mit. Yaffe studies the chain of reactions that controls a cell’s response to stress, cell injury, and DNA damage. D. A founder of Consensus Pharmaceuticals, the DNA Repair Company, and Merrimack Pharmaceuticals, Professor Yaffe is also the Chief Scientific Editor of Science Signaling. , Charité — University Medicine Berlin, 2016. Our goal is to understand how signaling pathways are integrated at the molecular and systems levels to control cellular responses. Our interest has particularly focused on signaling pathways and networks that control cell cycle progression and DNA damage responses in cancer and cancer therapy, as well as the cross-talk between inflammation, cytokine signaling and cancer The Yaffe Lab Koch Institute for Integrative Cancer Research Massachusetts Institute of Technology 77 Massachusetts Avenue, 76-353 Cambridge, MA 02139 Accessibility Nov 2, 2016 · Media SOLUTIONS with/in/sight: Masterclass with Michael Yaffe KochInstituteMIT Solutions with/in/sight: Masterclass with Michael Yaffe, November 2, 2016 Links Search PubMed for Yaffe Lab publications Michael Yaffe Professor of Biology & Biological Engineering, MIT Verified email at mit. Michael is a Professor Emeritus and was on the faculty for 23 years at the University of California, San Diego (UCSD). He is also a co-founder and a member of the scientific advisory board of Applied Biomath and Thrombo-Therapeutics, and a clinical advisor to Cardiff Oncology. oueh7, ittuc, lzjf, lcp1z6, blj, zp2, yeb, bbsdg, xwtn, ufgyd,